Chemistry:Levophacetoperane

From HandWiki
Revision as of 01:40, 16 March 2024 by JMinHep (talk | contribs) (fixing)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Stimulant drug
Levophacetoperane
Phacetoperane chemical structure.png
Clinical data
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • BR: Class C1 (Other controlled substances)
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC14H19NO2
Molar mass233.311 g·mol−1
3D model (JSmol)
  (verify)

Levophacetoperane (Lidépran, Phacétoperane) is a psychostimulant developed by Rhône-Poulenc in the 1950s.[1] The drug has been used as an antidepressant and anorectic.[2][3] It is the reverse ester of methylphenidate.

See also

References

  1. Marie JN, Michel JR, "New esters", US patent 2928835, published 15 March 1960, assigned to Rhône-Poulenc
  2. "Isolation and detection of methylphenidate, phacetoperane and some other sympatomimetic central nervous stimulants with special reference to doping. I. Gas chromatographic detection procedure with electron capture detection for some secondary amines". Journal of Chromatography 106 (2): 412–7. March 1975. doi:10.1016/S0021-9673(00)93853-6. PMID 239015. 
  3. Konofal E, Figadere B, "Phacetoperane for the treatment of attention-deficit hyperactivity disorder", US patent 20150038533, published 5 February 2015, assigned to Assistance Publique – Hôpitaux de Paris